Current Edition

Upcoming Events

Advertisement

news

With new trial, Pfizer and BioNTech will test whether an omicron vaccine is needed

Dive Brief: Pfizer and BioNTech have begun enrolling patients in a study testing a new version of their COVID-19 vaccine specifically tailored to the omicron varia...
Continue Reading →
news

Moderna follows Pfizer in beginning trial of omicron vaccine

Dive Brief: Moderna on Wednesday said it has begun a trial testing a new version of its COVID-19 vaccine that's tailored to the omicron variant, one day after Pfiz...
Continue Reading →
news

Adagio, after bold promises, says antibody drug won’t work well against omicron

The findings are a huge disappointment for Adagio, which billed ADG20 as a weapon that could neutralize a wide range of variants and help with future outbreaks. The c...
Continue Reading →
news

Sanofi, GSK say COVID vaccine works as booster, but delay key study results

Sanofi and GSK expected to have definitive results for their long-delayed coronavirus vaccine by now, having redesigned their shot after an initial formulation disapp...
Continue Reading →
news

Vaccine from Medicago, GSK protective against COVID-19 in large study

Most of the vaccines approved to date use either messenger RNA or DNA to coax the body's cells to produce the spike protein, or are synthetic versions of the spike th...
Continue Reading →
news

AstraZeneca antibody cleared by FDA for preventive use against COVID-19

AstraZeneca's drug, called Evusheld, is the fifth COVID-19 antibody treatment authorized by the FDA, and the fourth now available after Lilly pulled one of its two me...
Continue Reading →
news

Regeneron warns its antibody drug may be less potent versus omicron

Regeneron's drug is the top-selling COVID-19 treatment in the U.S., one of three antibody drugs currently authorized by the Food and Drug Administration for people wh...
Continue Reading →
news

FDA, aiming to curb another COVID-19 surge, clears Pfizer, Moderna boosters for all adults

The Food and Drug Administration on Friday authorized COVID-19 booster shots for all vaccinated Americans over 18, a move that's meant to stem a rise in coronavirus i...
Continue Reading →
news

Pfizer again asks FDA to authorize COVID-19 boosters for all adults

Agency advisers had opposed a broad booster dose clearance in September, leading the FDA to limit use to older adults and those at high risk of COVID-19. Pfizer and ...
Continue Reading →
news

CDC panel unanimously backs use of Pfizer’s COVID-19 vaccine in young children

The CDC meeting Tuesday emphasized COVID-19's cost on young children, who, while less at risk than older adults, are still susceptible to disease, hospitalization and...
Continue Reading →